Register to leave comments

  • News bot Jan. 31, 2026, 10:20 a.m.

    📋 Avita Medical Ltd (RCEL) - Clinical Trial Update

    Filing Date: 2026-01-13

    Accepted: 2026-01-13 08:30:27

    Event Type: Clinical Trial Update

    Event Details:

    Avita Medical Ltd (RCEL) Announces Clinical Trial Update Avita Medical Ltd (RCEL) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: million, outlook
    • Collaboration: New Debt Facility
    • Updated Timeline: full year 2024, the fourth quarter of 2025
      • expected in the range of approximately $80 to $85 million, representing growth of approximately 12% to 19% compared to 2025

    🔬 Clinical Development Pipeline (Avita Medical Ltd):

    Product Type Development Stage Therapeutic Area Source
    ReCell Treatment DEVICE Approved Burns ClinicalTrials.gov
    Cohealyx DEVICE Approved Burn ClinicalTrials.gov
    Frozen Human Cadaveric Allograft (FHCA) DEVICE Approved Surgical Wound ClinicalTrials.gov
    PermeaDerm Biosynthetic Wound Matrix DEVICE Approved Surgical Wound ClinicalTrials.gov
    smART+ REE DEVICE Preclinical Comparative Study ClinicalTrials.gov
    Standard Care OTHER Phase PHASE4 Venous Leg Ulcers ClinicalTrials.gov
    Standard Care plus ReCell DEVICE Phase PHASE4 Venous Leg Ulcers ClinicalTrials.gov
    ReGenerCell™ Autologous Cell Harvesting Device DEVICE Phase PHASE4 Diabetic Foot Ulcer ClinicalTrials.gov
    smARTrack Feeding Tube System DEVICE Approved Aspiration Pneumonia ClinicalTrials.gov
    ReNovaCell DEVICE Approved Non-segmental Vitiligo ClinicalTrials.gov
    ReCell and Split-thickness skin graft DEVICE Approved Burns ClinicalTrials.gov
    RECELL 1:20 and Ultraviolet Lamp (UVB) DEVICE Approved Vitiligo ClinicalTrials.gov
    RECELL 1:10 and Ultraviolet Lamp (UVB) DEVICE Approved Vitiligo ClinicalTrials.gov
    RECELL 1:5 and Ultraviolet Lamp (UVB) DEVICE Approved Vitiligo ClinicalTrials.gov
    Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB) PROCEDURE Approved Vitiligo ClinicalTrials.gov
    smART Feeding Tube System DEVICE Preclinical Aspiration Pneumonia ClinicalTrials.gov
    Pulsed Electric Field Ablation PROCEDURE Approved Atrial Fibrillation ClinicalTrials.gov
    Pulsed Field Ablation of epicardial Ganglionated Plexi. DEVICE Approved Atrial Fibrillation ClinicalTrials.gov
    Skin Graft PROCEDURE Approved Burns ClinicalTrials.gov
    RECELL® Autologous Cell Harvesting Device DEVICE Approved Vitiligo ClinicalTrials.gov
    smART+ System DEVICE Approved Aspiration Pneumonia ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Avita Medical Ltd
    • Ticker Symbol: RCEL